Insmed to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
11 Juillet 2006 - 2:19PM
Business Wire
Insmed Incorporated (NASDAQ:INSM) today announced that Philip J.
Young, Chief Business Officer of Insmed, will present a corporate
overview on Wednesday, July 12 at 1:35 PM ET during the C.E.
Unterberg, Towbin Emerging Growth Opportunities Conference taking
place in New York. Investors may access a live audio webcast of the
presentation via http://www.wsw.com/webcast/ceut4/insm/. About
Insmed Insmed is a biopharmaceutical company focused on the
discovery and development of drug candidates for the treatment of
metabolic diseases and endocrine disorders with unmet medical
needs. For more information, please visit http://www.insmed.com.
Forward Looking Statements Statements included within this press
release, which are not historical in nature, may constitute
forward-looking statements for the purposes of the safe harbor
provided by the Private Securities Litigation Reform Act of 1995.
Forward-looking statements in this press release include, but are
not limited to, statements regarding the pending litigation and or
future ability to conduct our business as now conducted and as it
is currently proposed to be conducted. Such forward-looking
statements are subject to numerous risks and uncertainties,
including but not limited to the uncertainty of the outcome of any
litigation with Tercica. We can give no assurances that we would be
successful in any litigation or that such litigation would not have
a material adverse effect on our business, financial condition and
results of operation. Furthermore, we may not be able to afford the
expense of defending against such a claim. As a result of these and
other risks and uncertainties, actual results may differ materially
from those described in this press release. For further information
with respect to factors that could cause actual results to differ
from expectations, reference is made to reports filed by the
Company with the Securities and Exchange Commission under the
Securities Exchange Act of 1934, as amended.
Insmed (NASDAQ:INSM)
Graphique Historique de l'Action
De Juin 2024 à Juil 2024
Insmed (NASDAQ:INSM)
Graphique Historique de l'Action
De Juil 2023 à Juil 2024